Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database.
about
Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid.Quantitative neuropathological assessment to investigate cerebral multi-morbidity.Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and ChallengesThe Clinical and Health Economic Value of Clinical Laboratory DiagnosticsThe Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis.Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease.The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.The impact of β-amyloid positron emission tomography on the diagnostic and treatment decisions of dementia experts.Piramal Imaging.Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal StudiesF-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease
P2860
Q34214255-9A15C43C-399A-48A6-90F0-1D8761752F44Q34584768-4DE0194E-2DBA-4CB3-84C3-BA6B68F335F4Q35765058-5F307C80-34EC-4B68-9A39-866F62E43757Q36724441-AFE1CCDE-651F-4E21-85D0-4E61EFE24B15Q37053888-506E7598-DB8D-4647-AFAD-FF7D3E8E8798Q37155167-4C56D7CF-215C-432C-B81E-68F8BD3133B6Q39017659-6B81D033-C0BC-451A-9BB5-185CB3CD8744Q39215443-8FBD5F9C-D306-447A-9EF6-05C169393DB5Q40444811-9BBB3FE4-C936-4DE9-8E00-AFBC634C145AQ50606067-5061C007-75DC-476C-A521-62FF676E0519Q52839697-6C29D387-2490-4292-B237-75D868CCE61CQ52863012-4C542300-0174-428D-BDD2-11246EA16D41Q57482388-DD727B79-0651-40B2-888E-06924FA8FEC7Q58733228-02321023-1898-4C0B-B02B-63677F1942B0
P2860
Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characteristics of patients mi ...... ysis of the NACC-UDS database.
@ast
Characteristics of patients mi ...... ysis of the NACC-UDS database.
@en
type
label
Characteristics of patients mi ...... ysis of the NACC-UDS database.
@ast
Characteristics of patients mi ...... ysis of the NACC-UDS database.
@en
prefLabel
Characteristics of patients mi ...... ysis of the NACC-UDS database.
@ast
Characteristics of patients mi ...... ysis of the NACC-UDS database.
@en
P2093
P2860
P50
P356
P1433
P1476
Characteristics of patients mi ...... ysis of the NACC-UDS database.
@en
P2093
David L Roth
Joseph E Gaugler
Tolulope Fafowora
P2860
P2888
P356
10.1186/1471-2318-13-137
P577
2013-12-19T00:00:00Z
P5875
P6179
1047265775